首页> 美国卫生研究院文献>Stem Cells and Development >Neuregulin-1β Induces Mature Ventricular Cardiac Differentiation from Induced Pluripotent Stem Cells Contributing to Cardiac Tissue Repair
【2h】

Neuregulin-1β Induces Mature Ventricular Cardiac Differentiation from Induced Pluripotent Stem Cells Contributing to Cardiac Tissue Repair

机译:神经调节蛋白1β诱导成熟的心室分化从诱导多能干细胞有助于心脏组织修复。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Stem cell-derived cardiomyocytes (CMs) are often electrophysiologically immature and heterogeneous, which represents a major barrier to their in vitro and in vivo application. Therefore, the purpose of this study was to examine whether Neuregulin-1β (NRG-1β) treatment could enhance in vitro generation of mature “working-type” CMs from induced pluripotent stem (iPS) cells and assess the regenerative effects of these CMs on cardiac tissue after acute myocardial infarction (AMI). With that purpose, adult mouse fibroblast-derived iPS from α-MHC-GFP mice were derived and differentiated into CMs through NRG-1β and/or dimethyl sulfoxide (DMSO) treatment. Cardiac specification and maturation of the iPS was analyzed by gene expression array, quantitative real-time polymerase chain reaction, immunofluorescence, electron microscopy, and patch-clamp techniques. In vivo, the iPS-derived CMs or culture medium control were injected into the peri-infarct region of hearts after coronary artery ligation, and functional and histology changes were assessed from 1 to 8 weeks post-transplantation. On differentiation, the iPS displayed early and robust in vitro cardiogenesis, expressing cardiac-specific genes and proteins. More importantly, electrophysiological studies demonstrated that a more mature ventricular-like cardiac phenotype was achieved when cells were treated with NRG-1β and DMSO compared with DMSO alone. Furthermore, in vivo studies demonstrated that iPS-derived CMs were able to engraft and electromechanically couple to heart tissue, ultimately preserving cardiac function and inducing adequate heart tissue remodeling. In conclusion, we have demonstrated that combined treatment with NRG-1β and DMSO leads to efficient differentiation of iPS into ventricular-like cardiac cells with a higher degree of maturation, which are capable of preserving cardiac function and tissue viability when transplanted into a mouse model of AMI.
机译:干细胞衍生的心肌细胞(CM)通常在电生理上是不成熟和异质的,这代表了它们在体外和体内应用的主要障碍。因此,本研究的目的是检查神经调节蛋白-1β(NRG-1β)处理是否可以增强诱导多能干(iPS)细胞体外成熟的“工作型” CMs的产生,并评估这些CMs的再生作用。急性心肌梗塞(AMI)后的心脏组织。出于此目的,通过NRG-1β和/或二甲基亚砜(DMSO)处理,从α-MHC-GFP小鼠中获得了成年小鼠成纤维细胞衍生的iPS,并将其分化为CM。通过基因表达阵列,定量实时聚合酶链反应,免疫荧光,电子显微镜和膜片钳技术分析了iPS的心脏规格和成熟度。在体内,将iPS衍生的CM或培养基对照注射入冠状动脉结扎后的心脏梗死周围区域,并在移植后1至8周评估其功能和组织学变化。在分化方面,iPS显示出早期且稳定的体外心脏发生,表达心脏特异性基因和蛋白质。更重要的是,电生理研究表明,与单独使用DMSO相比,用NRG-1β和DMSO处理细胞可获得更成熟的心室样心脏表型。此外,体内研究表明,源自iPS的CM能够植入并与心脏组织机电耦合,最终保留了心脏功能并诱导了适当的心脏组织重塑。总而言之,我们已经证明,NRG-1β和DMSO联合治疗可将iPS有效分化为成熟度更高的心室样心肌细胞,当移植到小鼠模型中时能够保留心脏功能和组织活力AMI。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号